Navigation Links
Amgen Announces Voting Results Of Annual Meeting Of Stockholders
Date:5/6/2009

THOUSAND OAKS, Calif., May 6 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN), today announced results of voting at the company's Annual Meeting of Stockholders, held at The St. Regis Hotel, San Francisco, Calif. Approximately 87.3 percent of outstanding shares were represented at the meeting.

The director nominees: David Baltimore, Frank J. Biondi, Jr., Francois de Carbonnel, Jerry D. Choate, Vance D. Coffman, Frederick W. Gluck, Frank C. Herringer, Gilbert S. Omenn, Judith C. Pelham, J. Paul Reason, Leonard D. Schaeffer and Kevin W. Sharer were each reelected to Amgen's Board of Directors, each receiving a majority of "For" votes of the votes cast. Each was elected by no less than 86.7 percent of the votes cast. With the reelection of these directors, Amgen currently has 12 directors.

With approximately 98.7 percent of "For" votes of the votes cast, stockholders ratified Ernst & Young LLP as Amgen's independent registered public accountants for the year ending Dec. 31, 2009.

Stockholders approved the Amgen 2009 Equity Incentive Plan, which authorizes the issuance of up to 100,000,000 shares of Amgen common stock. The proposal was approved with approximately 81.2 percent of votes cast "For."

Stockholders approved the proposed amendment to the company's Restated Certificate of Incorporation, as amended, to reduce the sixty-six and two-thirds percent (66-2/3%) voting requirement in the company's Restated Certificate of Incorporation, as amended, to a simple majority voting requirement for approval of certain business combinations. Approximately 84.4 percent of the outstanding shares of our common stock were in favor of the amendment.

Stockholders approved a nonbinding resolution recommending that the company amend its Amended and Restated Bylaws, as amended, to permit holde
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
2. Preclinical Data From Amgens Oncology Pipeline to be Presented at AACR
3. Amgen to Present at the Cowen and Company Annual Healthcare Conference
4. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
5. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
6. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
7. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
8. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
9. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
10. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
11. Amgen to Webcast 2008 Business Review Meeting on November 7 From Millennium Hotel in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
(Date:10/22/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... Oral Amphotericin B program.  The company recently announced ... work involving samples from HIV/AIDS patients exposed to ... clinical studies and regulatory filings to move forward ... approximately $700,000 of funding and technological advice from ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... Convey Computer , the leader in ... State University won first place in the 2014 ... the team’s solution achieved the highest overall performance in ... place finisher. , Experts from all segments of the ... challenge, using a variety of design tools, hardware and ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... 18 W. R. Grace & Co. (NYSE: ... Court for the District of Delaware of the previously announced ... as of September 13, 2010 pursuant to which W. R. ... & Co., will purchase Synthetech, Inc. (OTC Bulletin Board: ...
... work done at the Department of Energy,s Oak Ridge ... unexpected magnetism between two dissimilar materials. The results, ... for the design of future electronic devices for computations ... Materials Science and Technology Division. The work was performed ...
... Reportlinker.com announces that a new market ... Global Automated And Rapid ... http://www.reportlinker.com/p092467/Global-Automated-And-Rapid-Microbiological-Tests-Industry.html This report analyzes ... Microbiological Tests in US$ Million by the ...
Cached Biology Technology:Synthetech Announces Bankruptcy Court Approval of Merger With W. R. Grace Subsidiary 2Synthetech Announces Bankruptcy Court Approval of Merger With W. R. Grace Subsidiary 3ORNL theorist part of team that discovers unexpected magnetism 2Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 2Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 3Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 4Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 5Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 6Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 7Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 8Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 9Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 10Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 11Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 12Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 13Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 14Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 15Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 16Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 17Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 18Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 19Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 20Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 21Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 22Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 23Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 24Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry 25
(Date:10/17/2014)... release is available in German . ... a very few drugs. When treating overdoses, doctors are often ... especially difficult if there is a combination of drugs involved. ... and accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux ... to find an answer to this question. "The task was ...
(Date:10/16/2014)... have challenged conventional thinking on how the bowel lining ... for how bowel cancer starts. , The researchers produced ... regenerating the ,crypts, that are a feature of the ... in bowel cancer development, a controversial finding as scientists ... Using 3D imaging technologies, Dr Chin Wee Tan and ...
(Date:10/16/2014)... 16, 2014 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... including Wocket™, the Smart Wallet, at the 13 th ... a leading global conference on the intersection of technology ... Mark Anderson , founder and publisher of the Strategic ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Cryptic clues drive new theory of bowel cancer development 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
... in some regions and increasing global demand for high ... water globally. This was the main conclusion of a ... Education. The special report follows a strategic workshop ... rules of international trade" held on 25th - 26th ...
... at the Genome Institute of Singapore (GIS) have, for ... comes with a guarantee on its reliability when reconstructing ... streamlined process for reconstructing and studying genomic sequences. ... of Computational and Mathematical Biology at the GIS, was ...
... fish have a greater capacity to cope with rising sea ... The discovery, by researchers at the ARC Centre of ... sheds a ray of hope amid the rising concern over ... levels of global warming expected to occur by the end ...
Cached Biology News:Experts call on governments, industries and the water and trade research communities 2Researchers at GIS develop systematic approach for accurate DNA sequence reconstruction 2When the heat's on, fish can cope 2When the heat's on, fish can cope 3
...
p27 rabbit polyclonal antibody...
... Rabbit polyclonal to Ki67 - Proliferation Marker, ... cell cycle related nuclear protein, expressed by ... active cell cycle (G1, S, G2 and ... (G0) cells. Ki67 antibodies are useful in ...
UBC13 Antibody...
Biology Products: